Barclays’ research review of the recent acquisition of Coventry Health Care, Inc. (NYSE:CVH) by Aetna Inc. (NYSE:AET) is highly appreciative of the merger.
Though the stock rating for Aetna Inc. (NYSE:AET) is maintained unchanged at Overweight, and so is the Price Target at $55, it would be useful to look at the many factors that are highlighted in the report, and which are expected to work in favor of the acquisition.
- On an overall basis, the merger would be a win-win for both parties. Coventry Health Care, Inc. (NYSE:CVH) shareholders get a very decent price that may well...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
